DRG Market Assessment reports
Access comprehensive market intelligence covering Disease Landscape & Forecast, Epidemiology Intelligence, Biosimilars Intelligence, China In-depth and more.
Post-Traumatic Stress Disorder | Treatment Algorithms: Claims Data Analysis | US | 2023
Multiple guidelines recommend treating post-traumatic stress disorder (PTSD) first with psychotherapy, but such approaches do not suffice for many patients, necessitating the use of pharmacological…
Major Depressive Disorder | Treatment Algorithms: Claims Data Analysis | US | 2023
Major depressive disorder (MDD) is a highly drug-treated condition that uses an array of drug classes, including, but not limited to, selective serotonin reuptake inhibitors (SSRIs), selective…
Irritable Bowel Syndrome | Treatment Algorithms: Claims Data Analysis | IBS-constipation (including IBS without diarrhea) | US | 2023
Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by alterations in motility, stool consistency and frequency, and urgency. It is classified into three subtypes:…
Crohn’s Disease | Treatment Algorithms: Claims Data Analysis | Adult | US | 2023
Crohn’s disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract characterized by diarrhea, abdominal pain, and weight loss. The primary goal of CD treatment is to induce and…
Generalized Anxiety Disorder | Treatment Algorithms: Claims Data Analysis | US | 2023
The use of pharmacotherapies for the treatment of generalized anxiety disorder (GAD) has grown sharply, fueled by an increasing prevalence of the disorder and constrained access to nonpharmacologic…
